A Compact Analytical Profile of Aripiprazole: Analytical Methodologies

Athira, O. V. and Rishad, Muhamed and Babu, K. Anand and Praseetha, K. and Indukala, . and Kathirvel, S. (2021) A Compact Analytical Profile of Aripiprazole: Analytical Methodologies. Journal of Pharmaceutical Research International, 33 (34A). pp. 7-19. ISSN 2456-9119

[thumbnail of 2642-Article Text-4324-1-10-20221006.pdf] Text
2642-Article Text-4324-1-10-20221006.pdf - Published Version

Download (327kB)

Abstract

Aripiprazole (APZ) is an antipsychotic drug that belongs to benzisoxazole derivatives and is used to treat schizophrenia as well as acute manic or mixed effects in patients with bipolar 1 disorder. APZ is used to treat certain mental, mood disorders such as bipolar disorder, Schizophrenia, Tourette's syndrome, and irritability associated with autistic disorder. It may also be used in combination with other medication to treat depression. The present review article would be useful for prospective studies for researchers interested in APZ formulation production and quality management. Using a thorough computer assisted literature survey; this review touches upon the various reported analytical methods for the quantification of APZ both in API (Active Pharmaceutical Ingredient) and pharmaceutical dosage forms. The present write-up also encompasses the various published research articles like Spectroscopy techniques, X- Ray Diffraction (XRD), Electro Chemical Technique, Differential Scanning Calorimeter (DSC) and Capillary Electrophoresis. This is the first review article in this series with focus on the analytical profile of APZ. Although, several methods were reported in the literature, HPLC stands out first for the quantification of APZ.

Item Type: Article
Subjects: Opene Prints > Medical Science
Depositing User: Managing Editor
Date Deposited: 25 Apr 2023 04:48
Last Modified: 04 May 2024 04:28
URI: http://geographical.go2journals.com/id/eprint/1061

Actions (login required)

View Item
View Item